We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLTR icon
351
Dollar Tree
DLTR
$25.2B
– –
-4,248
Closed -$421K
DRI icon
352
Darden Restaurants
DRI
$24.4B
– –
-36,443
Closed -$7.94M
EAT icon
353
Brinker International
EAT
$9.66B
– –
-125,827
Closed -$22.7M
ENLV icon
354
Enlivex Ltd
ENLV
$35M
– –
-94,220
Closed -$1.58M
ENR icon
355
Energizer
ENR
$1.55B
– –
-536,000
Closed -$10.8M
FGIWW
356
FGI Industries Warrant
FGIWW
$217K
– –
-933,333
Closed -$41K
FWRG icon
357
First Watch Restaurant Group
FWRG
$766M
– –
-350,000
Closed -$5.61M
GKOS icon
358
Glaukos
GKOS
$10.6B
– –
-31,438
Closed -$3.25M
HST icon
359
Host Hotels & Resorts
HST
$16B
– –
-398,687
Closed -$6.12M
IBRX icon
360
ImmunityBio
IBRX
$8.1B
– –
-7,764,000
Closed -$20.5M
IOT icon
361
Samsara
IOT
$23.8B
– –
-9,912
Closed -$394K
IVP
362
DELISTED
Inspire Veterinary Partners
IVP
– –
-60,000
Closed -$101K
JNJ icon
363
Johnson & Johnson
JNJ
$625B
– –
-75,218
Closed -$11.5M
KMX icon
364
CarMax
KMX
$8.26B
– –
-30,295
Closed -$2.04M
LCFYW icon
365
Locafy Ltd Warrant
LCFYW
– –
-12,121
Closed -$126K
LLY icon
366
Eli Lilly
LLY
$1.06T
– –
-3,898
Closed -$3.04M
MMM icon
367
3M
MMM
$94.3B
– –
-2,232
Closed -$340K
MNTS icon
368
Momentus
MNTS
$92.7M
– –
-44,370
Closed -$966K
MO icon
369
Altria Group
MO
$114B
– –
-4,216
Closed -$247K
NLSPW
370
DELISTED
NLS Pharmaceutics Warrant
NLSPW
– –
-12,500
Closed -$250
NXLIW
371
DELISTED
Nexalin Technology Inc Warrant
NXLIW
– –
-325,000
Closed -$15.4K
NXTC icon
372
NextCure
NXTC
$26.7M
– –
-8,667
Closed -$47.8K
OTRK
373
DELISTED
Ontrak
OTRK
– –
-356,666
Closed -$178K
PDSB icon
374
PDS Biotechnology
PDSB
$43.4M
– –
-2,236,000
Closed -$2.97M
PFGC icon
375
Performance Food Group
PFGC
$18B
– –
-280,000
Closed -$24.5M
12 13 14
15
16

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.